Showing results (281-290 of 2,599) with videos related to

Sort By:
Pageof 260
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1978
Vulnerability factors and depression in womenA Roy
Archives of General Psychiatry|March 1, 1981
Depression in the course of chronic undifferentiated schizophreniaA Roy
Archives of Neurology|July 1, 1979
Hysterical seizuresA Roy
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteersA K Malhotra, D A Pinals, H Weingartner, et al.
The American Journal of Psychiatry|February 1, 1988
Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defectR C Shelton, C N Karson, A R Doran, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1997
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenicsA K Malhotra, D A Pinals, C M Adler, et al.
Psychoneuroendocrinology|January 1, 1990
Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humansO M Wolkowitz, N M Papadopoulos, R Costello, et al.
Journal of Clinical Psychopharmacology|August 1, 1993
Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot studyR E Litman, W W Hong, E M Weissman, et al.
Archives of General Psychiatry|February 15, 2001
Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findingsR C Daly, T P Su, P J Schmidt, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1993
Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twinsM H Rapaport, E F Torrey, C G McAllister, et al.
Pageof 260